& Boissy, R
A higher body mass index is often linked to this pattern, especially when excess weight is carried around the abdomen
This combination, marketed as CagriSema, represents a pipeline medication
While all of these compounds belong to the growth hormone secretagogue family, they operate differently
Data that support use of acetylsalicylic acid-free strategies are limited, and such strategies should not be advocated for use in routine clinical practice unless they are supported by clinical trial evidence
Important factors affecting GLP-1 market demand and take-up include: The need for better long-term data on the safety and efficacy of use for the designated indications The rapidly expanding list of potential new indications for the drugs, including chronic kidney disease, broader cardiovascular risk reduction, metabolic liver disease, and Alzheimer's disease The number of similar drugs in the development pipeline Price point versus competition, which affects affordability and insurance coverage Marketing efforts of the manufacturers, supply and distribution constraints
